Remedy Entertainment’s revenue grew 43.4% to €30.3 million in H1 2025, driven by the performance of Control, Alan Wake 2, and the launch of FBC: Firebreak.
02
The company achieved a positive operating profit of €0.8 million and an EBITDA of €6.8 million, a significant turnaround from the €3.6 million EBITDA loss recorded in H1 2024.
03
A strategic shift toward self-publishing has succeeded, with over 50% of total revenue now generated from game sales and royalties rather than external development fees.
04
Despite improved profitability, the company reported a negative operating cash flow of €3.5 million, primarily due to the timing of development-fee receipts and €6.1 million in capitalized development costs.
05
The balance sheet remains strong with an equity ratio of 72.8%, total assets of €97.5 million, and €10.0 million in cash and equivalents as of June 30, 2025.
06
The company’s workforce grew by 6.6% year-over-year to 385 employees, supporting its ongoing development and self-publishing operations.
Insights
01
Remedy Entertainment’s revenue grew 43.4% to €30.3 million in H1 2025, driven by the performance of Control, Alan Wake 2, and the launch of FBC: Firebreak.
02
The company achieved a positive operating profit of €0.8 million and an EBITDA of €6.8 million, a significant turnaround from the €3.6 million EBITDA loss recorded in H1 2024.
03
A strategic shift toward self-publishing has succeeded, with over 50% of total revenue now generated from game sales and royalties rather than external development fees.
04
Despite improved profitability, the company reported a negative operating cash flow of €3.5 million, primarily due to the timing of development-fee receipts and €6.1 million in capitalized development costs.
05
The balance sheet remains strong with an equity ratio of 72.8%, total assets of €97.5 million, and €10.0 million in cash and equivalents as of June 30, 2025.
06
The company’s workforce grew by 6.6% year-over-year to 385 employees, supporting its ongoing development and self-publishing operations.